We Doc Pharmaceuticals Private Limited
About We Doc Pharmaceuticals Private Limited
Data last updated:
We Doc Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 27 October 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL1998PTC096832. Its GSTIN is 07AAACW2511K1ZH (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.86 Lakh. It is led by directors Nagendra Kumar Sinha and Manoj Kumar.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 80 Ganesh Nagar 2nd Floor Pandav Nagar Complex, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.85 Lakh, a decline of 38% compared to the previous year. For the same year it recorded a net loss of ₹59,247 (net margin -3.5%) and EBITDA of -₹57,725 (EBITDA margin -3.4%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC – 80 Ganesh Nagar 2nd Floor Pandav Nagar Complex, Delhi, India – 110092
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of We Doc Pharmaceuticals Private Limited
The main business activity of We Doc Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of We Doc Pharmaceuticals Private Limited FY 2025 filings available
We Doc Pharmaceuticals Private Limited reported revenue of ₹16.85 Lakh (down 38% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of We Doc Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 38% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of We Doc Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹57,725 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹59,247 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of We Doc Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -3.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of We Doc Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of We Doc Pharmaceuticals Private Limited
We Doc Pharmaceuticals Private Limited is audited by UKS & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| UKS & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of We Doc Pharmaceuticals Private Limited
We Doc Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagendra Kumar Sinha | Director | 27 Oct 1998 | 27 Years 11 Months | Current |
| Manoj Kumar | Director | 27 Oct 1998 | 27 Years 11 Months | Current |
Ownership and Shareholding of We Doc Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of We Doc Pharmaceuticals Private Limited
We Doc Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at We Doc Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to We Doc Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on We Doc Pharmaceuticals Private Limited
We Doc Pharmaceuticals Private Limited has 2 board changes on record since 1998: 2 appointments. The latest: Manoj Kumar was appointed as Director on 27 Oct 1998.
Credit Ratings, Litigation & Regulatory Alerts for We Doc Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by We Doc Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of We Doc Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of We Doc Pharmaceuticals Private Limited
We Doc Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACW2511K1ZH | Delhi | Active | 01 Jul 2017 |
| 24AAACW2511K1ZL | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of We Doc Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about We Doc Pharmaceuticals Private Limited
We Doc Pharmaceuticals is an active private limited company based in Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 27 October 1998 (28+ years old) and is registered under CIN U24233DL1998PTC096832.
We Doc Pharmaceuticals reported revenue of ₹16.85 Lakh for FY 2025 (down 38% YoY).
We Doc Pharmaceuticals has 2 current directors:
- Nagendra Kumar Sinha - Director
- Manoj Kumar - Director
We Doc Pharmaceuticals reported a net loss of ₹59,247 (net margin -3.5%) and EBITDA of -₹57,725 (EBITDA margin -3.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of We Doc Pharmaceuticals is -16% over three years and -2% over five years. In the latest year (FY 2025) revenue fell 38%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of We Doc Pharmaceuticals is 07AAACW2511K1ZH, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAACW2511K1ZL (Gujarat).
The CIN (Corporate Identification Number) of We Doc Pharmaceuticals is U24233DL1998PTC096832. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
We Doc Pharmaceuticals was incorporated on 27 October 1998, making it 28+ years old. It is registered with the Registrar of Companies, Delhi.
Manoj Kumar was appointed as Director on 27 Oct 1998. Nagendra Kumar Sinha was appointed as Director on 27 Oct 1998.
The registered office of We Doc Pharmaceuticals is at C – 80 Ganesh Nagar 2nd Floor Pandav Nagar Complex, Delhi, India – 110092.